FDA gains explicit power to investigate foodborne illness at large farms
H.R. 852 — Expanded Food Safety Investigation Act of 2025 · Filed by Rosa DeLauro (D-CT) · 15 cosponsors · Introduced Jan 31, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill gives the FDA explicit authority to request access to large-scale animal farms (concentrated animal feeding operations, or CAFOs) to collect microbial samples during foodborne illness outbreak investigations or to address other public health needs. The farm must grant reasonable access, though it can set reasonable conditions on timing and manner of sampling as long as those conditions don't prevent the FDA from sampling within a reasonable timeframe. The bill does not expand FDA authority over meat, poultry, or eggs (which remain under USDA jurisdiction) and requires the FDA to share data with USDA and state/federal health agencies.
Why we flagged it
The bill is a straightforward grant of investigative authority to a federal health agency to address a documented public health risk (foodborne illness outbreaks). It is not a subsidy, carve-out, or deregulation—it is an expansion of FDA's power to protect consumers.
What the text implies
- Farms may face increased inspection frequency and operational disruption during outbreak investigations, though the bill permits reasonable conditions on access timing and manner.
- The requirement to share microbial data with USDA and state agencies may reveal farm-level contamination patterns that could trigger additional regulatory scrutiny or public disclosure.
- The definition of CAFO is tied to EPA regulations (40 CFR 122.23(b)), so changes to EPA's CAFO definition would automatically expand or contract the bill's scope without further congressional action.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands FDA's ability to investigate and prevent foodborne illness outbreaks by enabling direct microbial sampling at large animal farms, which are a known source of contamination. Citizens benefit from faster outbreak investigation, earlier intervention, and reduced risk of foodborne illness. The access requirement is balanced—farms can set reasonable conditions but cannot obstruct sampling.
Named in the bill
FDA (Food and Drug Administration), USDA (U.S. Department of Agriculture), Concentrated Animal Feeding Operations (CAFOs), Federal Food, Drug, and Cosmetic Act, Federal Meat Inspection Act, Poultry Products Inspection Act, Egg Products Inspection Act, EPA (Environmental Protection Agency)
Where it stands
15 cosponsors: 15 Democrats.
- Jan 31, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jan 31, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,618 characters) on Jun 3, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“FDA gains explicit power to investigate foodborne illness at large farms” QuorumCivic. https://share.quorumcivic.app/bill/119/hr852 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.